Stephen J. Galli - 13 May 2022 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Role
Director
Signature
/s/ Stephen J. Galli, M.D.
Issuer symbol
ATOS
Transactions as of
13 May 2022
Transactions value $
$0
Form type
4
Filing time
16 May 2022, 18:23:21 UTC
Previous filing
18 May 2021
Next filing
05 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOS Stock Option (right to buy) Award $0 +50K $0.00 50K 13 May 2022 Common Stock 50K $0.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:30 a.m. (ET) on May 13, 2022, with an exercise price of $0.93, representing the most recently reported closing stock price on May 12, 2022.